COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,725 Articles (22,913 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 2371: Articles 23701-23710  | Next

Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning
Navlakha, S., Morjaria, S., Perez-Johnston, R., Zhang, A., Taur, Y.
10.1101/2020.08.23.20179838 — Posted: 2020-08-25
The Relationship between Deteriorating Mental Health Conditions and Longitudinal Behavioral Changes in Google and YouTube Usages among College Students in the United States during COVID-19: Observational Study
Zaman, A., Zhang, B., Hoque, E., Silenzio, V., Kautz, H.
10.1101/2020.08.22.20178640 — Posted: 2020-08-25
The Role of Machine Learning Techniques to Tackle COVID-19 Crisis: A Systematic Review.
Syeda, H. B., Syed, M., Sexton, K. W., Syed, S., Begum, S., Syed, F., Yu, F.
10.1101/2020.08.23.20180158 — Posted: 2020-08-25 Discussion: Offsite
Impacts of K-12 school reopening on the COVID-19 epidemic in Indiana, USA
Espana, G., Cavany, S., Oidtman, R. J., Barbera, C., Costello, A., Lerch, A., Poterek, M., Tran, Q., Wieler, A., Moore, S. M., Perkins, A.
10.1101/2020.08.22.20179960 — Posted: 2020-08-25 Discussion: Onsite
Monitoring COVID-19 transmission risks by RT-PCR tracing of droplets in hospital and living environments
Piana, A., Colucci, M. E., Valeriani, F., Marcolongo, A., Sotgiu, G., Pasquarella, C., Margarucci, L. M., Petrucca, A., Gianfranceschi, G., Babudieri, S., Vitali, P., D'Ermo, G., Bizzarro, A., De Maio, F., Vitali, M., Azara, A., Romano, F., Simmaco, M., Romano Spica, V.
10.1101/2020.08.22.20179754 — Posted: 2020-08-25
The influence of major S protein mutations of SARS-CoV-2 on the potential B cell epitopes
Yuan, X., Li, L.
10.1101/2020.08.24.264895 — Posted: 2020-08-24
Induction of SARS-CoV-2 protein S-specific CD8+ T cells in the lungs of gp96-Ig-S vaccinated mice
Fisher, E., Padula, L., Podack, K., O'Neill, K., Seavey, M. M., Jayaraman, P., Jasuja, R., Strbo, N.
10.1101/2020.08.24.265090 — Posted: 2020-08-24
Flagellin from Pseudomonas aeruginosa increases the expression of the SARS-CoV2 entry protease TMPRSS2 in airway epithelial cells
Ruffin, M., Bigot, J., Calmel, C., Corvol, H., Balloy, V., Guillot, L.
10.1101/2020.08.24.264564 — Posted: 2020-08-24
The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting viral replication-transcription complex in culture cells
Matsuyama, S., Kawase, M., Nao, N., Shirato, K., Ujike, M., Kamitani, W., Shimojima, M., Fukushi, S.
10.1101/2020.08.22.258459 — Posted: 2020-08-24 Discussion: Offsite
SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model
Haagmans, B. L., Noack, D., Okba, N. M. A., LI, W., Wang, C., Bestebroer, T., de Vries, R., Herfst, S., de Meulder, D., van Run, P., Lamers, M. M., Rijnders, B., Rokx, C., van Kuppeveld, F. J. M., Grosveld, F., Drabek, D., GeurtsvanKessel, C., Koopmans, M., Bosch, B. J., Kuiken, T., Rockx, B.
10.1101/2020.08.24.264630 — Posted: 2020-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).